ResMed leads sleep apnea market with strong growth and margin improvements, rated Buy with 12% safety margin.
ResMed (RMD) dominates the sleep apnea market with a 62% share in a large, under-penetrated market offering significant growth potential. The company benefits from a razor-and-blade business model, strong brand loyalty, and recurring revenue from low...
